Unknown PHASE4 INTERVENTIONAL NCT00106886

HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)

Sponsor: Canadian Institutes of Health Research (CIHR)

Conditions Cancer Cardiovascular Disease Myocardial Infarction Stroke

Interventions Folic acid, vitamin B6 and B12 or placebo

Updated 5 times since 2017 Last updated: Sep 16, 2005 Started: Dec 31, 1999 Completion: Oct 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00106886, this PHASE4 trial focuses on Cancer and Cardiovascular Disease and remains ongoing. Sponsored by Canadian Institutes of Health Research (CIHR), it has been updated 5 times since 1999, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Dec 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Canadian Institutes of Health Research (CIHR)
Hamilton Health Sciences Corporation
Population Health Research Institute

Data source: McMaster University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamilton, Canada